Fundraising Fox

Pharmaceutics International

Hunt Valley, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

SE
Syed E Abidi, Ph.D.Director
JF
John FowlerExecutive Officer, Director
SE
Syed E. AbidiExecutive Officer, Director
SI
Sana I. AbidiDirector
JH
Julien HechtExecutive Officer
SR
Shahid RazaDirector
JD
Jillian DettingerExecutive Officer
DS
David SolomonDirector
MK
Mark KavulichDirector
JG
James GaleDirector
MB
Michael BogdaDirector

Investors · 1

Signet Healthcare PartnersreportedNew York · $10M – $50M

Reported raises · per SEC filings

Form D private placements
▶$11.2MraisedOct 2024 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David SolomonDirector
  • Mark KavulichDirector
  • Syed E Abidi, Ph.D.Director
  • John FowlerExecutive Officer, Director
  • Michael BogdaDirector
  • James GaleDirector
Offering amount
$11.2M
Amount sold
$11.2M
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedMar 2024 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James GaleDirector
  • Syed E. Abidi, Ph.D.Director
  • Mark KavulichDirector
  • John FowlerExecutive Officer, Director
  • Michael BogdaDirector
  • David SolomonDirector
  • Joseph KielyExecutive Officer
Offering amount
$4.2M
Amount sold
$4.2M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedJun 2023 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John FowlerExecutive Officer, Director
  • Mark KavulichDirector
  • Syed E. Abidi, Ph.D.Director
  • Michael BogdaDirector
  • David SolomonDirector
  • James GaleDirector
  • Joseph KielyExecutive Officer
Offering amount
$12M
Amount sold
$6M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedDec 2022 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph KielyExecutive Officer
  • Mark KavulichDirector
  • Michael BogdaDirector
  • John FowlerExecutive Officer, Director
  • Syed E. Abidi, Ph.D.Director
  • James GaleDirector
  • David SolomonDirector
Offering amount
$3M
Amount sold
$3M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9MraisedOct 2022 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Syed E. Abidi, Ph.D.Director
  • James E. GaleDirector
  • John GuthrieExecutive Officer
  • Sana I. AbidiDirector
  • David SolomonDirector
  • John FowlerExecutive Officer, Director
  • Michael BogdaDirector
Offering amount
$9M
Amount sold
$9M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedAug 2022 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Syed E. Abidi, Ph.D.Director
  • David SolomonDirector
  • Shahab N. AbidiDirector
  • John GuthrieExecutive Officer
  • John I. FowlerExecutive Officer, Director
  • James E. GaleDirector
  • Michael BogdaDirector
Offering amount
$5M
Amount sold
$5M
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJul 2022 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James GaleDirector
  • Shahab N. AbidiDirector
  • Michael I. BogdaDirector
  • Syed E. AbidiDirector
  • John FowlerExecutive Officer, Director
  • John GuthrieExecutive Officer
  • David SolomonDirector
Offering amount
$5M
Amount sold
$5M
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedMay 2022 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John FowlerExecutive Officer, Director
  • James GaleDirector
  • Michael BogdaDirector
  • John GuthrieExecutive Officer
  • Sana AbidiDirector
  • Syed E. AbidiDirector
  • David SolomonDirector
Offering amount
$5M
Amount sold
$5M
First sale
Apr 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.